» Articles » PMID: 32335406

Factors Associated with Negative Conversion of Viral RNA in Patients Hospitalized with COVID-19

Overview
Date 2020 Apr 27
PMID 32335406
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Factors associated with negative conversion of SARS-CoV-2 RNA in hospitalized patients have not yet been systematically determined. We conducted a retrospective cohort study of COVID-19 patients in Qingdao, China. Both univariate and multivariate analysis were performed to identify independent factors for time to viral RNA negative conversion. Data on patients with re-detectable viral RNA after showing negative on RT-PCR test (intermittent negative status) were also analyzed. A total of 59 patients confirmed with COVID-19 were included in this study, with a median duration of 1 (interquartile range, IQR: 0-2) day from symptom onset to hospital admission. Median communicable period (from first day of positive nucleic acid test to first day of consecutive negative results) was 14 (IQR: 10-18) days, and 7 (IQR: 6-10) days for 10 patients with intermittent negative results. Age older than 45 years (hazard ratio, HR: 0.378; 95% confidence interval, CI: 0.205-0.698) and chest tightness (HR: 0.290; 95%CI: 0.091-0.919) were factors independently affecting negative conversion of SARS-CoV-2 RNA. Headache (odds ratio: 7.553; 95%CI: 1.011-28.253) was significantly associated with intermittent negative status, with a predicted probability of 60%. Older age and chest tightness were independently associated with delayed clearance of SARS-CoV-2 RNA in hospitalized patients. These predictors would provide a new perspective on early identification of patients with prolonged viral shedding and facilitate optimal isolation protocols and treatment strategies.

Citing Articles

Estimating the association between cigarette and e-cigarette use patterns and SARS-CoV-2 negative conversion time: retrospective online survey in China.

Xie Y, Li Y, Su Z, Han X, Liu Z, Huang Z BMC Infect Dis. 2025; 25(1):161.

PMID: 39901130 PMC: 11792595. DOI: 10.1186/s12879-025-10545-x.


Survival of hospitalised COVID-19 patients in Hawassa, Ethiopia: a cohort study.

Anteneh A, LeBlanc M, Natnael A, Asfaw Z BMC Infect Dis. 2024; 24(1):1055.

PMID: 39333929 PMC: 11429985. DOI: 10.1186/s12879-024-09905-w.


A retrospective analysis of the influencing factors of nucleic acid CT value fluctuation in COVID-19 patients infected with Omicron variant virus in Changchun city.

Cao Z, Sun F, Ding H, Tian Z, Cui Y, Yang W Front Public Health. 2024; 12:1377135.

PMID: 38947348 PMC: 11211536. DOI: 10.3389/fpubh.2024.1377135.


The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review.

Latarissa I, Meiliana A, Sormin I, Sugiono E, Wathoni N, Barliana M Front Pharmacol. 2024; 15:1383359.

PMID: 38873430 PMC: 11169809. DOI: 10.3389/fphar.2024.1383359.


Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study.

Wang Y, Yu H, Zhang T, Sun Z, Yao W, Zhang W Virus Res. 2024; 345:199400.

PMID: 38763300 PMC: 11137596. DOI: 10.1016/j.virusres.2024.199400.


References
1.
Jia J, Hu X, Yang F, Song X, Dong L, Zhang J . Epidemiological Characteristics on the Clustering Nature of COVID-19 in Qingdao City, 2020: A Descriptive Analysis. Disaster Med Public Health Prep. 2020; 14(5):643-647. PMC: 7156571. DOI: 10.1017/dmp.2020.59. View

2.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

3.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

4.
Pan Y, Zhang D, Yang P, Poon L, Wang Q . Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020; 20(4):411-412. PMC: 7128099. DOI: 10.1016/S1473-3099(20)30113-4. View

5.
Wolfel R, Corman V, Guggemos W, Seilmaier M, Zange S, Muller M . Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581(7809):465-469. DOI: 10.1038/s41586-020-2196-x. View